Bral solutie injectabila 2500 mg + 10 mg + 0,1 mg/ Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

bral solutie injectabila 2500 mg + 10 mg + 0,1 mg/

micro labs ltd - metamizoli de sodiu + pitofenonum + fenpiverini bromidum - solutie injectabila - 2500 mg + 10 mg + 0,1 mg/

Bral comprimate 500 mg + 5 mg + 0,1 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

bral comprimate 500 mg + 5 mg + 0,1 mg

micro labs ltd - metamizoli de sodiu + pitofenonum + fenpiverini bromidum - comprimate - 500 mg + 5 mg + 0,1 mg

Spikevax (previously COVID-19 Vaccine Moderna) Uniunea Europeană - română - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.